Industry Updates
Magazine
Brand Story
Press Release
BLOGS
Meet Dr. Ratan Chaudhuri, the founder, President, and CEO of Sytheon Ltd., an innovative research-based company committed to developing high-performance active ingredients for the personal care industry since 2006. Sytheon is a U.S.-based company with European and Asian affiliates in France and Singapore.
Born and raised in India, Dr. Chaudhuri pursued his first job at the University of Bonn, Germany. Later, he joined the Swiss Federal Institute of Technology in Switzerland before accepting a new role at the University of Wisconsin, Madison, in 1980.
Dr. Chaudhuri joined his first industrial job at ISP Chemicals in 1985, and later in 1996, he moved to EMD Chemicals as the Technical Director of Personal Care. He served EMD Chemicals for over a decade and gained valuable experience and insights into the personal care industry, which he leveraged to create Sytheon in 2006.
Providing Long Lasting Solutions for Skin Protection & Repair of Photoaging
Each and every active ingredient in Sytheon’s portfolio is inspired by nature and ‘built for performance.’ These active ingredients are scientifically and clinically validated to improve the health and beauty of the skin.
Currently, the organization’s portfolio includes products like Sytenol® A, Hydra Synol® DOI, Asyntra® SL, Synoxyl® AZ, Synovea® HR, Synovea® EL, Asyntra® D-Stress, Vitasynol® C, Synactin® AC, Synoxyl® HSS and Synastol® TC. In line with its top ingredient Sytenol®A (Bakuchiol), these other prominent ingredients all help fight aging and pollution, promote hydration and well-aging and provide needed solutions to combat existing skin problems or enhance skin’s defenses against the damaging effects of sun exposure.
Sytheon’s Asyntra® D-Stress is a revolutionary patent-pending ingredient that synergizes with CBD/Hemp oil to augment its most positive attributes. Combination of the two ingredients helps lower Cortisol levels to help manage inflammation while simultaneously strengthening skin’s barrier function for a smoother and more hydrated, radiant-looking skin.
Yet another innovation from Sytheon is Synoxyl® AZ (Acetyl Zingerone), a multi-targeted antiaging molecule designed to counteract aging before it happens and to reverse key signs of photo-damaged skin. AZ prevents skin damage and nurtures skin’s own ability to maintain the integrity of the ECM for optimal health and appearance of skin throughout life. Key attributes of Synoxyl® AZ include: (1) high efficiency as an Omni-Antioxidant to scavenge/quench reactive oxygen species & selectively chelate iron – First-in-the Industry; (2) ability to reduce both immediate & delayed direct DNA damage (↓CPDs) – First-in-the Industry; (3) robust photochemical stability in contrast to many conventional antioxidants; (4) proven clinical efficacy to improve appearance of photoaged skin with significant reductions in wrinkles, pigmentation and skin redness without using sunscreens; (5) balances skin microbiome diversity and stimulates skin friendly Staph. Epidermidis.
Under Dr. Chaudhuri’s leadership, Sytheon initiated in-depth research on Sytenol® A (Bakuchiol), the first natural alternative to Retinol without any of the main drawbacks associated with Retinol. A recent study conducted by Dr. Sivamani at UC-Davis and published by the British Journal of Dermatology concluded that Bakuchiol is comparable to Retinol in its ability to improve photoaging and is better tolerated than Retinol. This study eventually spiked the interest in Sytenol® A to an unprecedented level and became a new gold standard in anti-aging products.
Tackling Challenges
During Sytheon’s early developmental phase, Dr. Chaudhuri tackled multiple challenges. As a new company, Sytheon at first had to earn the trust and confidence within the industry for the quality and consistency of their ingredients plus demonstrate sound supply chain reliability, which resulted in relatively slow growth during the early years. However, with focus and dedication to needs of their customers, Dr. Chaudhuri and his team has today transformed Sytheon into one of the most trusted companies within the industry.
Dr. Chaudhuri believes that one of the chief challenges faced by companies is to stay at the forefront of innovation by continually seeking new ideas and then implementing them to fuel business growth. When the coronavirus pandemic struck and most of the world went into strict lockdown, many companies failed to stand their ground. However, at Sytheon Dr. Chaudhuri and his team changed their strategy to a smart online campaign to showcase their unique portfolio of products, which resulted in phenomenal growth in 2020 and 2021.
Dr. Chaudhuri works with his team to strengthen Sytheon’s credibility every day by delivering high-quality, unique, science-based solutions with proven efficacy to its customers.
Satisfied Clientele
Johnson & Johnson was the first multi-national company to use Synovea® HR, the gold standard in skin lightening. Clinically proven to be four times more effective than Hydroquinone, Synovea® HR has demonstrated strong performance in skin lightening during multiple clinical studies and provides the best ratio between safety and performance as a skin lightener and toner. Mary Kay has also approved the use of Synovea® HR in their products. Synovea® HR is now the gold standard in skin lightening and a very sought-after product for skin brightening in a wide range of skin care products.
Preparing for the Future
Dr. Chaudhuri expects Sytheon to grow further with the new state-of-the-art corporate headquarters at Parsippany, New Jersey, USA and a new affiliate in Singapore for the Asian market along with expansion of product portfolio. A new team is now focused on various hair care products that cater to unmet needs of the hair dyeing process and hair protection through various marketing partnerships.
